Project Summary

Human papillomavirus- (HPV-) related cancers, including cervical and oropharyngeal cancers, are serious public health concerns. Each year, nearly 26,800 new cases of HPV-related cancers are reported. For many, HPV-related cancers are completely avoidable. However, many children, adolescents, and young adults who are eligible to receive vaccines to prevent these cancers have yet to be immunized.

To inform future comparative effectiveness research that leads to interventions to increase HPV vaccination uptake and reduce avoidable cancers, inclusion of diverse stakeholders with varying areas of expertise and life experience are needed during every phase of the research process.

The primary objective of this project is to expand our existing community coalition board (CCB) to plan, design, and develop an effective comparative effectiveness research project to increase HPV vaccination rates among children and adolescents. The CCB will convene regular meetings over the project period and work closely with the research team to develop the strategic direction of the research program, including finalizing a comparative effectiveness research question and partnering with state and national stakeholders to develop and disseminate effective interventions to increase HPV vaccine rates among children and adolescents.

View Tier I Award

Project Information

Angela Myers, MD, MPH
Children's Mercy Hospital

Key Dates

12 months


Award Type
State State The state where the project originates, or where the primary institution or organization is located. View Glossary
Last updated: March 4, 2022